Abstract
Pituitary tumors correspond to 10 to 15% of intracranial tumors and its prevalence reaches as much as 27% in autopsy studies of the population (1). These tumors may be classified as microadenomas (diameter <10 mm) and macroadenomas (>10 mm), and could be enclosed, expansive and/or invasive (2). Prolactin-secreting adenomas (prolactinomas) are the most common of the pituitary-secreting tumors, and its prevalence is estimated at 500 cases/1,000,000 inhabitants (3). The incidence of prolactinomas is four times greater in women than in men; the microadenomalmacroadenoma ratio is approximately 3:1 in women. Since hyperprolactinemia is usually associated with anovulation, and prolactinomas present a greater incidence in the 3rd and 4th decades, these tumors are an important cause of infertility. Its treatment very frequently restores the hypothalamus-pituitary-ovary axis and it is expected to result in pregnancies. This chapter addresses the management of pregnancy in patients with prolactinomas submitted to different treatments, assessing their results and the deleterious effects on mother and fetus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burrow, G.N., Wortzman, G., Rewcastle, H.B., Holgate, R.C., and Kovacs, K. 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy.N Engl J Med304:156
Hardy, J. 1973 Transsphenoidal surgery of hypersecreting pituitary tumors. InDiagnosis and treatment of pituitary tumors.P.O. Kohler and G.T. Ross, editors. Amsterdam: Excerpta Medica, pp.179.
Miyai, K., Ichihara, K., Kondo, K., and Mori, S. 1986 Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin.Clin Endocrinol (Oxf)25:549–54
Hardy, J. 1969 Transsphenoidal microsurgery of the normal and pathological pituitary.Clin Neurosurg16:185–217
Corenblum, B., Webster, B.R., Mortimer, C.B., et al. 1975 Possible anti-tumor effect of 2 patients with large prolactin-secreting pituitary adenomas.Clin Res23:61
Marino Jr, R. and Bronstein, M.D. 1988 The role of pituitary surgery in the treatment of prolactinomas. InClinical Endocrinology: Proceedings of the 18th Brazilian Congress of Endocrinology and MetabolismRio de Janeiro, Junho 12–17, 1988 R.M.R. Meireles, A. Machado, and L.C. Póvoa, editors. Amsterdam-New York-Oxford Excepta Medica,. pp:12–17.
Molitch, M.E. 1999 Medical treatment of prolactinomas.Endocrinol Metab Clin North Am28:143–69
Berezin, M., Avidan, D., and Baron, E. 1991 Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dipaminergic drugs.Isr J Med Sci27::375–9
Webster, J. 1996 A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.Drug Saf14:228–38
Musolino, N.R.C., Cunha Neto, M.B., and Bronstein, M.D. 2000 Cabergolina como alternativa no tratamento clinico de prolactinomas. Experiência na intolerância/resistência a bromocriptina.Arq Bras Endocrinol Metab44:139–43
Colao, A., Di Sarno, A., Sarnacchiaro, F., Ferone, D., Di Renzo, G., Merola, B., Annunziato, L., and Lombardi, G. 1997 Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment.J Clin Endocrinol Metab82:876–83
Duranteau, L., Chanson, P., Lavoinne, A., Horlait, S., Lubetzki, J., and Kuhn, J. M. 1991 Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.Clin Endocrinol (Oxf)34:205–502
Verhelst, J., Abs, R., Maiter, D., van der Bruel, A., Vandeweghe, M., Velkeniers, B., Mockel, J., Lamberigts, G., Petrossians, P., Coremans, P., Mahler, C., Stevenaert, A., Verlooy, J., Raftopoulos, C., and Beckers, A. 1999 Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.J Clin Endocrinol Metab84:2518–22
Cannavo, S., Curto, L., Squadrito, S., Almoto, B., Vieni, A., and Trimarchi, F. 1999 Cabergoline: a first-choice treatment in patients with previously untreated prolactinsecreting pituitary adenoma.J Endocrinol Invest22:354–9
Fahlbusch, R. and Buchfelder, M. 1985 Present status of neurosurgery in the treatment of prolactinomas.Neurosurg Rev8:195–205
Soule, S.G., Farhi, J., Conway, G.S., Jacobs, H.S., and Powell, M. 1996 The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.Clin Endocrinol (Oxf)44:711–6
Turner, H.E., Adams, C.B., and Wass, J.A. 1999 Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists ?Eur J Endocrinol140:43–7
Bronstein, M.D., Musolino, N.R., Benabou, S., and Marino Jr, R. 1989 Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas.JSurg Neurol32:346–9
Jalali, R., Brada, M., Perks, J.R., Warrington, A.P., Traish, D., Burchell, L., McNair, H., Thomas, D.G., Robinson, S., and Johnston, D.G. 2000 Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.Clin Endocrinol (Oxf)52:695–702
Inoue,H.K.,Kohga,H.,Hirato, M.,Sasaki,T.,Shihara,J.,Shibazaki, T.,Ohye,C.,and Andou Y.1999 Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: experience in 122 cases.Stereotact Funct Neurosurg72:125–31
Morange-Ramos, I., Regis, J., Dufor, H., Andrieu, J.M., Grisou, F., Jaquet, P., and Peragaut, J.C. 1998 Short-term endocrinological results after gamma knife surgery of pituitary adenomas.Stereotact Funct Neurosurg70:127–38
Elster, A.D., Sanders, T.G., Vines, F.S., and Chen, M.Y. 1991 Size and shape of the pituitary gland during pregnancy and post partum: measurement with M R imaging.Radiology181:531–5
Dinc, H., Esen, F., Demirci, A., Sari, A., and Resit Gumele, H. 1998 Pituitary dimensions and volume measurements in pregnancy and post partum M R assessment.Acta Radiol39:64–9
Gonzalez, J.G., Elizondo, G., Saldriar, D., Nanez, H., Todd, L.E., and Vielarreal, J. Z. 1988 Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging.Am J Med85:217–20
Scheithauer, B.W., Sano, T., Kovacs, K.T., Young Jr, W.F., Ryan, N., and Randall, R.V. 1990 The pituitary gland in pregnancy: a cliniopathologic and immunohistochemical study of 69 cases.Mayo Clin Proc65:461–74
Rigg, L.A., Lein, A., and Yen, S.S.C. 1977 Pattern of increase in circulating prolactin levels during human gestation.Am J Obstet Gynecol129: 454–6
Ferriani, R.A., Silva de Sá, M.F., and Lima Filho, E.C. 1986 A comparative study of longitudinal and cross-sectional changes in plasma levels of prolactin and estriol during normal pregnancy.Brazilian J Med Biol Res19:183–8
Zegher, F., Spitz, B., Van der Berghe, G., Lemmens, D., Vanweser, K., Keppens, K., and Bowers, C.Y. 1998 Postpartum hyperprolactinemia and hyporesponsiveness of growth hormone to GH-releasing peptide.J Clin Endocrinol Metab83:103–6
Delvoye, P., Delogne-Desnoeck, J., and Robyn, C. 1980 Hyperprolactinaemia during prolonged lactation: evidence for anovulatory cycles and inadequate corpus luteum.Clin Endocrinol13:243–7
Magyar, D.M. and Marshall, J.R. 1978 Pituitary tumors and pregnancy.Am J Obstet Gynecol132:739–51
Gemzell, C. and Wang, C. F. 1979 Outcome of pregnancy in women with pituitary adenoma.Fertil Steril31:363–72
Krupp, P., and Monka, C. 1987 Bromocriptine in Pregnancy: Safety Aspects.Klin Wochenschr65:823–7
Weil, C. 1986 The safety of bromocriptine in long-term use: a review of the literature.Curr Res Opin10:25–51
Musolino, N., and Bronstein, M. 1999 Prolactinomas and pregnancy — Use of dopamine agonists: bromocriptine and cabergoline. Procedings of “The 6th International Pituitary Congress” Long Beach, California, p. 91 (Abstr.)
Molitch„ M.E. 1985 Pregnancy and the hyperprolactinemic woman.N Engl J Med312:1364–70
Ferrer-Barriendos, J., Millet, A., and Lucas-Pinilla, E. 1981 Necrosis de un prolactinoma durante el embarazo.Rev Esp Obst Gin40:578–85
Holmgren, U., Bergstrand, G., Hagenfeldt, K., and Werner, S. 1986 Women with prolactinoma — effect of pregnancy and lactation on serum prolactin and on tumour growth.Acta Endocrinol (Copenh)111:452–9
Crosignani, P.G., Ferrari, C., Scarduelli, C., Picciotti, M.C., Caldara, R., Malinverni, A. 1981 Spontaneous and induced pregnancies in hyperprolactinemic women.Obstet Gynecol58:708–13
Shewchuk, A.B., Adamson, G.D., Lessard, P., and Ejrin, C. 1980 The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea.Am J Obstet Gynecol136:659–66
Chil, D.F., Gordon, H., Mashiter, K., and Jopkin, G.F. 1975 Pregnancy, prolactin, and pituitary tumours.Br Med J4:87–9
van Roon, E.., van der Vijver, J.C.M., Gerretsen, G., Hekster, R.E.M., and Wattendorff, R.A. 1981 Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.Fertil and Steril36:173–7
Maeda, T., Ushiroyama, T., Okuda, K., Fujimoto, A., Ueki, M., and Sugimoto, O. 1983 Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy.Obstet Gynecol61:117–20
Brodsky, J.B., Cohen, E.N., Brown, B.W. Jr, Wu, M.L., and Whitcher, C. 1980 Surgery during pregnancy and fetal outcome.Am J Obstet Gynecol138:1165–7
Bergh, T., Nillius, S.J., and Wide, L. 1978 Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours.Br Med J1:875–880
Tan, S.L., and Jacobs, H.S. 1986 Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.Int J Gynaecol Obstet24:209–15
Canales, E.S., Garcia, I.C., Ruiz, J.E., and Zarate, A. 1981 Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.Fertil and Steril36:524–6
Konopka, P., Raymond, J.P., Merceron, R.E., and Seneze, J. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas.Am J Obstet Gynecol146:935–8
Molitch, M.E. 1998 Pituitary diseases in pregnancy.Semin Perir - ftol22:457–70
Morange, I., Barlier, A., Pellegrini, I., Brue, T., Enjalbert, A., and Jaquet, P. 1996 Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.Eur J Endocrinol135:413–20
Robert, E., Musatti L., Piscitelli, G., Ferrari, C. I. Pregnancy outcome after treatment with the ergot derivative, cabergoline.Reprod Toxico110: 333–7
Ciccarelli, E., Grottoli, S., Razzore, P., Gaia, D., Bertagna, A., Cirillo, S., Cammarota, T., Camanni, M., and Camanni, F. 1997 Long-term treatment with cabergoline, a new long-lasting ergoline derivative, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.J Endocrinol Invest20:547–51
Zárate, A., Canales, E.S., Alger, M., and Forsbach, G. 1979 The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.Acta Endocrinol (Copenh)92:407–12
Bronstein, M.D., Musolino, N.R., Cardim, C.S., and Marino Jr, R. 1988 Outcome of 52 pregnancies in hyperprolactinemic women.Rev Bras Ginecol Obstet10:175–178
Bronstein, M.D., Musolino, N.R., Cardim, C., Monteiro, M., Marino Jr, R. 1988 Repeatable depot-bromocriptine treatment for prolactinomas. InClinical Endocrinology: “Proceedings of the 18th Brazilian Congress of Endocrinology and Metabolism, Rio de Janeiro, Junho 12–17, 1988 R.M.R. Meireles, A. Machado, and L.C. Póvoa, editors. Amsterdam-New York-Oxford: Excepta Medica. 12–17.
Crosignani, P.G., Maffei, A.M., Severini, V., Cavioni, V, Maggioni, P., Testa, G.1992 Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women.Eur J Obstet Gynecol Reprod Biol44:175–80
Rjosk, H.K., Fahlbusch, R., and von Werder, K. 1982 Influence of pregnancies on prolactinomas.Acta Endocrino! (Copenh)100:337–46
Badawy, S.Z., Marziale, J.C., Rosenbaum, A.E., Chang, J.K., and Joy, S.E. 1997 The long-term effects of pregnancy and bromocriptine treatment on prolactinomas — the value of radiologic studies.Early Pregnancy3:306–11
Ahmed, M., al-Dossary, E., and Woodhouse, N.J. 1992 Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.Fertil Steril58:492–7
Peillon, F., Racadot, J., Moussy, D., Vila-Porcile, E., Olivier, L., and Racadot, O. 1978 Prolactin-secreting adenomas. A correlative study of morphological and clinical dataIn Treatament of pituitary adenomas.R. Fahlbusch, and K. Von Werder, editors. Stuttgart: Thiemi. pp.1 14
Freeman, R., Wezenter, B., Silvestein, M., Kuo, D., Weiss, K.L., Kantrowitz, A.B., and Schubart, U.K. 1992 Pregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidus.Fertil Steril58:427–9
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
de Castro Musolino, N.R., Bronstein, M.D. (2001). Prolactinomas and Pregnancy. In: Bronstein, M.D. (eds) Pituitary Tumors in Pregnancy. Endocrine Updates, vol 15. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1435-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1435-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5552-6
Online ISBN: 978-1-4615-1435-0
eBook Packages: Springer Book Archive